80 related articles for article (PubMed ID: 2886492)
1. Idiosyncratic neuroleptic response.
Harrop DS
J Clin Psychiatry; 1987 Aug; 48(8):344-5. PubMed ID: 2886492
[No Abstract] [Full Text] [Related]
2. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
[No Abstract] [Full Text] [Related]
3. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
[TBL] [Abstract][Full Text] [Related]
4. Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses.
Svestka J; Rysánek R; Cesková E; Náhunek K
Act Nerv Super (Praha); 1989 Apr; 31(1):35-6. PubMed ID: 2571220
[No Abstract] [Full Text] [Related]
5. Intraindividual comparison of the effect of perphenazine and of the combination of perphenazine and lithium in schizophrenia.
Rysánek R; Cesková E; Svestka J; Náhunek K
Act Nerv Super (Praha); 1989 Apr; 31(1):37-8. PubMed ID: 2571222
[No Abstract] [Full Text] [Related]
6. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
Svestka J; Cesková E; Rysánek R; Náhunek K
Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
[No Abstract] [Full Text] [Related]
7. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
8. Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients.
Levine J; Caspi N; Laufer N
Schizophr Res; 1997 Jul; 26(1):55-63. PubMed ID: 9376337
[TBL] [Abstract][Full Text] [Related]
9. The NIMH-CATIE Schizophrenia Study: what did we learn?
Lieberman JA; Stroup TS
Am J Psychiatry; 2011 Aug; 168(8):770-5. PubMed ID: 21813492
[No Abstract] [Full Text] [Related]
10. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
Nagase Y; Okubo Y; Toru M
Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo JR; Buchanan RW
Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
[No Abstract] [Full Text] [Related]
13. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
14. Interpreting the results of the CATIE study.
Luchins DJ
Psychiatr Serv; 2006 Jan; 57(1):139-40. PubMed ID: 16399979
[No Abstract] [Full Text] [Related]
15. [Education groups in neuroleptic treatment of schizophrenic patients].
Gaillard P; Degiovanni A; Parrot F
Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
[No Abstract] [Full Text] [Related]
16. [Treatment of schizophrenia: what the family doctor should know].
Gruber O; Falkai P
MMW Fortschr Med; 2008 May; 150 Suppl 2():16-9; quiz 20. PubMed ID: 18680837
[No Abstract] [Full Text] [Related]
17. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
19. [On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics (author's transl)].
Náhunek K; Svestka J; Cesková E
Cesk Psychiatr; 1981 Feb; 77(1):25-30. PubMed ID: 6113897
[No Abstract] [Full Text] [Related]
20. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
